After graduating from the Medical School, Vienna, Austria, Gerfried undertook postgraduate training in Family Medicine and Pharmacology at the Universities of Vienna, Austria, of Mainz and of the Saarland, and the General Hospital of Kaiserslautern, Germany. His research areas have been cardiovascular and metabolic pharmacology, endocrinology, epithelial transport as well as clinical pharmacokinetics and pharmacodynamics. Dr. Nell is board certified as general practitioner and pharmacologist and toxicologist. He is also Lecturer in Pharmacology at the Medical University of Vienna, Austria.
For the past 30 years Dr. Nell has gained an extensive experience in clinical development (Eli Lilly, Byk Gulden) and management in pharmaceutical medicine as former Medical Director for Ciba-Geigy and subsequently Novartis in Austria. Since 2003 he has been the founder and managing partner of the consultancy NPC Nell Pharma Connect Ltd and co-founder of Rokitan Ltd, a pharmaceutical company focused on developing niche products.
Dr. Nell is the past president of GPMed (Austrian Society for Pharmaceutical Medicine), past president IFAPP (International Federation of Associations of Pharmaceutical Physicians and Pharmaceutical Medicine), Member of the Austrian Society of Pharmacology (APHAR).
IFAPP Academy provides an online, continuing professional development course, Medical Affairs in Medicines Development, resulting in the Professional Certification, Certified Medicines Development (CMD).